DR

Dhananjay Rajaram Pawar

Active Director Designated Partner DIN 11079507
DIN 11079507 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhananjay Rajaram Pawar

Data last updated:

Dhananjay Rajaram Pawar is a Designated Partner at Bloodtestbuddy Healthcare Llp (since 2025).

DIN 11079507
Primary Designation Designated Partner
First Appointment 28 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Apr 20252025Active

Board colleagues of Dhananjay Rajaram Pawar

NameDINCompanyDesignation
Akash Sanjay Surana11079509Bloodtestbuddy Healthcare LlpDesignated Partner
Avdut Vijaykumar Kulkarni11079508Bloodtestbuddy Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Bloodtestbuddy Healthcare Llp
Premium access

Shareholding and investment profile for Dhananjay Rajaram Pawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhananjay Rajaram Pawar

Dhananjay Rajaram Pawar currently holds 1 directorship: Bloodtestbuddy Healthcare Llp (Designated Partner, since 28 Apr 2025).

Dhananjay Rajaram Pawar was first appointed on 28 Apr 2025 as Designated Partner at Bloodtestbuddy Healthcare Llp.

The current boards of Dhananjay Rajaram Pawar's companies include Akash Sanjay Surana (Bloodtestbuddy Healthcare Llp), Avdut Vijaykumar Kulkarni (Bloodtestbuddy Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available